March 23 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PROVIDES A BUSINESS UPDATE AND OUTLINES RESPONSE TO COVID-19 PANDEMIC
* MEDEXUS PHARMACEUTICALS INC - EXPECTS THAT COVID-19 WILL RESULT IN MEANINGFUL DELAYS IN ENROLLMENT OF PEDIATRIC TRIAL FOR IXINITY
* MEDEXUS PHARMACEUTICALS INC - REVENUE GROWTH IS LIKELY UNATTAINABLE THIS FISCAL YEAR
* MEDEXUS PHARMACEUTICALS INC - BELIEVES IMPACT OF COVID-19 ON ITS PRESCRIPTION DRIVEN BUSINESS WILL BE LIMITED
* MEDEXUS PHARMACEUTICALS INC - EXPECTS DELAY IN IXINITY PEDIATRIC TRIAL TO ENHANCE NEAR TERM CASH FLOW
* MEDEXUS PHARMACEUTICALS INC - COMPLETED A REDUCTION IN ITS WORK FORCE AT TIME OF ITS ACQUISITION OF IXINITY